1
David W Robertson, David T Wong, Joseph H Krushinski Jr: 3-aryloxy-3-substituted propanamines. Eli Lilly and Company, Robert A Conrad, Leroy Whitaker, June 11, 1991: US05023269 (65 worldwide citation)

The present invention provides 3-aryloxy-3-substituted propanamines capable of inhibiting the uptake of serotonin and norepinephrine.


2
Edward E Beedle, David W Robertson, David T Wong: Serotonin antagonists. Eli Lilly and Company, Robert A Conrad, Leroy Whitaker, May 7, 1991: US05013761 (60 worldwide citation)

This invention provides a method of selectively antagonizing the 5-HT.sub.1A receptor in mammals by administering aryloxypropanolamines. Novel aryloxypropanolamines are also claimed.


3
David W Robertson, David T Wong, Joseph H Krushinski Jr: 3-aryloxy-3-substituted propanamines. Eli Lilly and Company, Robert A Conrad, September 11, 1990: US04956388 (56 worldwide citation)

The present invention provides 3-aryloxy-3-substituted propanamines capable of inhibiting the uptake of serotonin and norepinephrine.


4
David W Robertson: Plant mat and method. Grass Ventures, Mason Fenwick & Lawrence, July 13, 1993: US05226255 (36 worldwide citation)

A mat for plant cultivation comprises upper and lower portions of non-woven fibers, substantially all of which are preferably natural, biodegradable fiber; an intermediate layer of bi-laterally stable plastic mesh, of high strength relative to the non-woven fiber layers, is structurally joined to th ...


5
David W Robertson: Ureteral stent with end-effector and related methods. Boston Scientific SciMed, September 27, 2005: US06949125 (28 worldwide citation)

A system and related methods for maintaining the patentcy of the ureter comprising a pusher tube having a pusher tube lumen and an inflate lumen disposed within a wall of the pusher tube and a urinary stent having a proximal and distal portions with an elongated body portion therebetween configured ...


6
David W Robertson, J Scott Hayes: 2-phenylimidazio (4,5-c) pyridines. Eli Lilly and Company, Robert A Conrad, Leroy Whitaker, July 19, 1988: US04758574 (23 worldwide citation)

This invention provides for certain 2-phenylimidazo[4,5-c]pyridines, their pharmaceutical formulations, and their use as positive inotropic agents, bronchodilators, vasodilators, and anticoagulants.


7

8
Jaswant S Gidda, Herbert A Kirst, David W Robertson: Method for treating gastrointestinal disorders. Eli Lilly and Company, Nancy J Harrison, Leroy Whitaker, April 24, 1990: US04920102 (17 worldwide citation)

Novel ring-contracted macrolides which enhance gastrointestinal motility and novel methods and compositions for treating gtastrointestinal disorders in animals with these macrolides and with certain other previously known ring-contracted macrolides are provided.


9
David W Robertson: Inotropic agents. Eli Lilly and Company, Robert A Conrad, October 14, 1986: US04617302 (15 worldwide citation)

This invention provides certain pyridazinone derivatives, their pharmaceutical formulations, and their use as positive inotropic agents.


10
John O McWeeney, Benjamin E Morris, David W Robertson, David I Freed, James F Schuermann, John B Golden, Jozef Slanda, Brian Keith Wells, Jesse Leonard Farris III, Michael S H Chu, Oscar R Carrillo Jr, Todd A Hall, Yem Chin, Mark L Adams: Medical visualization system with endoscope and mounted catheter. Boston Scientific Scimed, Finnegan Henderson Farabow Garrett & Dunner, April 12, 2011: US07922650 (14 worldwide citation)

The present invention is directed to features and aspects of an in-vivo visualization system that comprises a catheter having an access port leading to an interior lumen through which an image transmission member is routed, and an endoscope having an access port leading to an interior lumen through ...



Click the thumbnails below to visualize the patent trend.